Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20
538 Amyotrophic lateral sclerosis (ALS) ALS is a neurological disorder that causes progressive degeneration of the motor neurons in the brainstem, spinal cord and cerebral cortex
A great company to work with, without dealing with going into the dr
Injectable forms offer direct bioavailability for systemic or localized effects, which is common in tissue repair models
Standard Dosing Range In preclinical models, BPC-157 accelerated healing across tendon, muscle, and ligament tissue at doses ranging from 110 mcg/kg/day, making human application at 250750 mcg/day practical and safe. Sikiric et al., Current Pharmaceutical Design Injection vs
Systemic administration also worked, but local delivery produced the strongest results consistently
Mechanism of Action at the Cellular Level BPC-157 exerts its effects through multiple interconnected pathways: Angiogenesis Promotion BPC-157 upregulates vascular endothelial growth factor (VEGF) and VEGFR2 expression, stimulating the formation of new capillaries
US$ 27.21
US$ 20.07
US$ 23.51